Why Viking Therapeutics Stock Could Take Off Later This Year [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
Many healthcare companies are working on their own GLP-1 drugs in an effort to take market share, which could amount to billions of dollars in revenue. The race is one for companies to get to the market as quickly as possible with an approved treatment. One stock that is in the thick of things right now is Viking Therapeutics (NASDAQ: VKTX) . Although it doesn't have an approved drug just yet, it's moving in the right direction. And if it's successful, its shares could skyrocket. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » But even before it might obtain approval for its key drug, VK2735, there could be a catalyst that gives the healthcare stock a near-term boost, as the company could soon release data from a key clinical trial. Image source: Getty Images. VK2735 could be used for maintenance dosing
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics: An Equally Important Catalyst Ahead [Seeking Alpha]Seeking Alpha
- Viking Therapeutics (VKTX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $102.00 price target on the stock.MarketBeat
- Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics? [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics: Phase 3 Obesity Data Feels Like A Coin Toss (Rating Downgrade) [Seeking Alpha]Seeking Alpha
VKTX
Earnings
- 2/11/26 - Miss
VKTX
Sec Filings
- 3/10/26 - Form 4
- 2/11/26 - Form 10-K
- 2/11/26 - Form 8-K
- VKTX's page on the SEC website